Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2025 is -2.07% vs 924.99% in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2025 is -21.53% vs 25.42% in Mar 2024
Interest
YoY Growth in year ended Mar 2025 is -20.97% vs 0.52% in Mar 2024
Profit After Tax
YoY Growth in year ended Mar 2025 is -3.03% vs 20.31% in Mar 2024
Compare Profit and Loss Results of Vista Pharma.
Figures in Cr
standalone - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
10.00
33.00
-23.00
-69.70%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
10.00
33.00
-23.00
-69.70%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0%
Raw Materials Consumed
7.00
31.00
-24.00
-77.42%
Power & Fuel Cost
0.00
0.00
0.00
0%
Employee Cost
2.00
0.00
2.00
0%
Operating Expenses
0.00
0.00
0.00
0%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
0.00
0.00
0.00
0%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
0.00
0.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
14.00
32.00
-18.00
-56.25%
Operating Profit (PBDIT) excl Other Income
-4.00
0.00
-4.00
0%
Other Income
0.00
0.00
0.00
0%
Operating Profit (PBDIT)
-3.00
1.00
-4.00
-400.00%
Interest
0.00
0.00
0.00
0%
Profit before Depriciation and Tax
-4.00
1.00
-5.00
-500.00%
Depreciation
0.00
0.00
0.00
0%
Profit Before Taxation & Exceptional Items
-5.00
0.00
-5.00
0%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
-5.00
0.00
-5.00
0%
Provision for Tax
0.00
0.00
0.00
0%
Profit After Tax
-4.00
0.00
-4.00
0%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
-10.00
-31.00
21.00
67.74%
Profit Available for appropriations
-15.00
-31.00
16.00
51.61%
Appropriations
-15.00
-31.00
16.00
51.61%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
-0.79
0.34
-1.13
-332.35%
Profit And Loss - Net Sales
Net Sales 10.07 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -2.07% vs 924.99% in Mar 2024
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) -4.03 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -21.53% vs 25.42% in Mar 2024
Profit And Loss - Interest
Interest 0.96 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -20.97% vs 0.52% in Mar 2024
Profit And Loss - Profit After Tax
Profit After Tax -4.65 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -3.03% vs 20.31% in Mar 2024






